Skip to content

Clinical trials

Phase 2 Cholangiocarcinoma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Phase: Phase 2 Country / region: Italy Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20141
20151
20161
20172
20192
20211
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting4
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche2
Basilea Pharmaceutica1
EMD Serono Research & Development Institute, Inc.1
Fore Biotherapeutics1
Francesco De Cobelli1
Genzyme, a Sanofi Company1
Incyte Corporation1
Merck Sharp & Dohme LLC1
National Cancer Institute, Naples1
PCI Biotech AS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma14
Biliary Tract Neoplasms4
Gallbladder Neoplasms3
Ovarian Neoplasms3
Urinary Bladder Neoplasms3
Bile Duct Neoplasms2
Breast Neoplasms2
Carcinoma, Hepatocellular2
Pancreatic Neoplasms2
Acrocephalosyndactylia1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.